H.M. Ellis had preliminary evidence from reversion experiments that Ach is allelic to emc; (2) that the Ach heterozygous phenotype is suppressed by a duplication and enhanced by a deficiency of the AS-C; (3) that the dominant phenotype of Ach (bristle loss and vein shortening) is opposite that of emc loss-of-function alleles; (4) that points 1, 2, and 3 combined suggests that Ach is a hypermorphic allele of the emc locus.
Following the publication of this paper, Dr. J.W. Posakony (University of California, San Diego) reminded one of the authors (A.G.-B.) that several relevant findings had been communicated to A.G.-B verbally in March, 1987 . As listed by Dr. Prosakony, these findings were :
(1) That Dr. Posakony and H.M. Ellis had preliminary evidence from reversion experiments that Ach is allelic to emc; (2) that the Ach heterozygous phenotype is suppressed by a duplication and enhanced by a deficiency of the AS-C; (3) that the dominant phenotype of Ach (bristle loss and vein shortening) is opposite that of emc loss-of-function alleles; (4) that points 1, 2, and 3 combined suggests that Ach is a hypermorphic allele of the emc locus.
Point 1 is acknowledged on p. 328/329 in our paper. The remaining points were analyzed in our paper without mentioning the details that led J.W. Posakony and H.M. Ellis (unpublished work) to come to their conclusion (point 4). Certainly the conclusion in point 1 promoted our genetic experiments with Ach that later confirmed point 4. A.G.-B. wishes to apologize for failing to explicitly acknowledge the details in the personal communication and for quoting the material without written permission.
